My Medication Side Effects Are Too Popular

In the main propaganda business of some hospitals, the dermatology department, which was once less valued, has now also appeared on the homepage, and there are clear picture comparisons for everyone to see

to the effect.

The comparison of pictures in the hospital is more credible than the comparison of pictures on Pudu.

Then there are some short video platforms, which launched the activity of "one week change in hair volume"

Anyone who uploads two photos of everything,

, have the opportunity to participate in the lottery, the grand prize is a cash red envelope of 5999

Together, these promotion methods let people who have a lot of things know about Niufaling, and are willing to use it to save their dwindling hair.

"Xiaofu Zong, these marketing plans have been added together, and our vitality has been deeply rooted in the hearts of the people.

"And the people who were involved in the clinical trials came forward again and told everyone that their hair was fine and they didn't continue to lose a lot of hair.

"Although we have spent hundreds of millions for publicity, we basically no longer need publicity in the future, and there are no competitors in the market.

Fu Liang also looked at the market share table in his hand. Currently, the market share of hair growth products in hair growth products exceeds [-]%!

There are also some cheaper products, and some imported products are still on sale, but sales have plummeted.

In another month, the market share will exceed [-]%, and it will become the first choice for all hair loss treatment.

At that time, there was no need for any advertisements, and by word of mouth, hair growth could completely occupy the market.

Not a single one can beat!

Now for germinal,

, everyone has worked hard. Now many colleagues who produce anti-hair loss and hair growth products should hate us very much.

"It's everyone's credit

The smile on Fu Liang's face has not disappeared. The hair growth is selling well, and the energy points he has obtained are as much as 3.2, so he can develop more special effects faster.

new medicine.

"Mr. Fu, do you know what is said on the Internet now, saying that the effect of our revitalization is comparable to magic.

"It is also said that we have created a miracle, and this year's sales of Germinal will be the sales record of all medicines in the domestic market!

Next, can we start the warm-up promotion in overseas markets?

Fu Diantian nodded: "It's time to start.

It's nothing to sweep the domestic market, they will sweep the global market!

During this period, the clinical trials of thrombosis drugs were also carried out very quickly, and the effect was very amazing.

Whether it is prevention or treatment, doctors and patients are extremely satisfied.

Fu Liang muttered in his heart: "It's time to start shorting Pfizer's stock!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription! ! !

Chapter [-]: Short Pfizer Stock!

At Pfizer headquarters, board members sat together looking at last quarter's earnings report and discussing whether to adjust the direction of operations for the next quarter.

Everyone was talking about the proposed revision, Williams shook his head

"Chairman, fellow directors, I don't think we need to adjust at all. We lowered Viagra's global selling price and previously sold it to Tianlong Pharmaceuticals.

The technology authorized by Xinming Pharmaceuticals is not produced. We just increase the sales in the eastern market. The profit of this section should be improved.

"The price of the painkiller Lerica has also been reduced,

, although Sutongstop is well promoted, patients with pain will not wait for them to go on the market. Our sales depend on

is rising.

"The swelling and pain drugs that we are good at Pfizer are not only for the treatment of lung cancer, but also for the treatment of cancer tumors in various parts such as liver cancer, stomach pain, and intestinal cancer.

"A new drug from Xinming Pharmaceutical is still in clinical trials, and we are not sure whether it will have long-term side effects or make patients repeat the disease. Why should we be afraid?

"By lowering the selling price, our sales once again led other pharmaceutical companies in the third quarter, ensuring our No. [-] position among pharmaceutical companies.

"At this time, we must continue to maintain the strategy of 11 price reduction and promotion, so that doctors and patients are accustomed to our special drugs from Pfizer, so that they can be used in Xinming Pharmaceutical.

After the new drugs are launched, we will not let our drugs be eliminated directly.

Williams doesn't think the company's business strategy needs to be adjusted, and it's just right now.

The company's profits may decline next year, but this year is sure to exceed expected growth.

The money is made back this year and next year, isn't that bad?Next year, some upgraded prescriptions will be released.

still make money

If nothing else, Pfizer's anti-inflammatory drugs, lipid-lowering drugs, antihypertensive drugs, anti-thrombotic drugs, heart disease drugs, etc., are not very good?

Viagra will not be eliminated, after all, it can also treat pulmonary arterial hypertension, and it is available in pharmacies.

Painkillers may not be eliminated, at least they don't know the price of Sutongbu. If the price is too high, it may not be chosen by patients.

In the face of a drug that may snatch their market in the future, that is to temporarily affect Pfizer's stock price, but it will not affect Pfizer's revenue and profit this year.

And next year is not necessarily, what if there is a problem with the new drug of Xinming Pharmaceutical?Or what new special drugs have Pfizer developed?

Relying on the sale at a lower price, they not only increased the wrong sales, but also brought the stock price back to a market value of [-] billion US dollars.

If we continue to do this in the fourth quarter, the company's market value can grow even more,

Why adjust?

The only drug currently on the market of Xinming Pharmaceutical is Shengfaling. It has just started to promote in the North American market, but it has not yet started to sell.

Even if it is sales, how much influence does Pfizer have on them?

After discussing the company's other revolutions, I also felt that what Williams said was reasonable, then the company's business strategy did not need to be adjusted.

But at this time, Chairman Ai Bo Le said a piece of news that he had just heard.

"Dear directors, I got news from Wall Street that in overseas markets, some people have shorted our Pfizer stock, and now many financial

The branch managers are analyzing whether our financial statements are fraudulent.

"Once they find out that there is any unfavorable news for us, then they will definitely spend a lot of money to short our stock and let our

The stock price plummeted!

In the United States, interests come first.

It doesn't matter that they belong to the same country, but in the face of interests, they will not be polite.

During several financial crises in the United States, many financial giants in the United States have also made great profits, and they will not stop unless they encounter political axe obstruction.

After all, many companies rely on the financial market to make money, and short selling is also one of the normal means of the financial market.

The directors are all at a loss. Anyone dare to short our Pfizer stock at this time?

Crazy!

Our financial report for the third quarter is very beautiful. At this time, shorting, isn't it courting death!

.But hasn't this gone up?

Although their stock price has fallen a lot before, the market value has decreased by more than [-] billion US dollars

"You said, could it be Xinming Pharmaceutical? After all, it has been targeted by us for a long time. Xinyin Pharmaceutical has made a lot of money in the eastern market. Maybe they want to rebel.

hit. "There are directors who speculate

Williams immediately shook his head: "Impossible!

"Xinming Pharmaceutical did make some money in the eastern market, but how much? It's less than one billion US dollars. Excluding the cost and necessary operating funds, they

How many can be used?

"When Johnson & Johnson cooperated with Xinming Pharmaceutical, they only paid half of the money. In addition, they acquired Tianlong Pharmaceuticals, and at the same time gave up Tianlong Pharmaceuticals.

Medicine's many medicines, including our Viagra

"As far as I heard, they also sold the prescriptions they bought from Asabel Labs, leaving only the factories and sales channels and other assets into the new

Ming Pharmaceutical.

Now, whether it is Xinming Pharmaceutical or Fujia, there is not much money to use. They want to short our Pfizer stock with that little money?

"Besides, how could our Pfizer stock still fall? Our earnings report in the fourth quarter will be better, and our stock price will continue to rise. This year is expected to

Another ten percent increase!

The company's drugs are selling well, and 377 painkillers and Viagra have also withstood the impact. Investors still believe in Pfizer's strength.

Unless some bad news for Pfizer is broken out at this time, it will affect Pfizer's stock price.

But where's the bad news?

The directors of Pfizer also don’t think there is a problem. If it is really from the Fu family’s side, then the funds they can use are only one billion US dollars, compared to Pfizer’s.

Rui's market value of [-] billion US dollars, what is it?

[-]%, with [-] times leverage, it is only [-]%, which can move Pfizer's share price

Do they really think these directors are vegetarians?

Behind those directors are also many large investment institutions, or some consortiums, who can come up with [-] billion [-] million casually.

Without tens of billions of dollars, don't even think about affecting Pfizer's stock price!

Pfizer reports third-quarter financial results, leading all pharma peers in sales and profits

After Fu Gao saw it, he understood that Pfizer was still so arrogant, and he never expected the stock price to fall.

This time, he came to teach Pfizer a lesson.